Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

A YOUNG woman has revealed that in 14 weeks, she has lost three stone on Mounjaro. But although Jess now feels “healthier” ...

Wegovy, which was approved in 2021 for obesity, contains the same key ingredient as Ozempic, called semaglutide, while Mounjaro uses a slightly different one, tirzepatide.

Wegovy, Mounjaro, and Ozempic are viral TikTok sensations. But the societal impact can’t be measured in views. Michael Edenfield’s doctor calls him the Incredible Shrinking Man. Between ...

Saxenda is a daily injection and Wegovy, like Mounjaro, is a weekly injection. Mounjaro has shown more promising results, with a clinical trial finding participants lost up to 22.5% of their body fat.